BioNTech
2 stories
-
healthModerna CEO Warns Europe Is Vulnerable Without mRNA Manufacturing Capacity
Stéphane Bancel cautions that continental Europe lacks industrial mRNA infrastructure, leaving it exposed to future pandemics or bioterrorism, as Moderna shifts strategy toward cancer vaccines.
-
healthBioNTech to Shut Singapore Vaccine Plant by Feb 2027
German biotech firm BioNTech will close its Singapore manufacturing site as part of a strategic realignment amid heavy losses.